Carsten Thiel was born in Berlin; He graduated from Max Planck Institute for Biophysical chemistry. Has been a CEO in accompany of Abeona which is leading in general and cell Therapy and also an executive at Abeona Therapeutics Inc. He starts his day by connecting with family and then checks his emails for a few minutes and checking on trending international headlines. This gives him lone moments before work.

In a recent new release by Investors entitled: “Karyopharm Appoints Carsten Thiel, Ph.D., to its Board of Directors”; the company proudly introduces Current Chief Executive Officer of Abeona Therapeutics, Inc. and former Executive Vice President and Chief Commercial Officer of Alexion Pharmaceuticals, Inc.; which brings Wealth of Leadership and Global Strategic Experience.

Carsten Thiel prioritizes his time, considering the long effects not only daily achievements in his tasks. Spends a quarter of his time with company board and investors, to ensure that he maintains a cohesive unit. He interacts directly with customers, doctors, and the users of his product with 10% of his time. This helps in understanding how the clients are receiving the product.

Brings his ideas to live by encouraging teamwork. Thiel listens to everyone’s thoughts. He is excited by growing up in a family of medical practitioners. Technology also stimulates him for it helps to make things that looked impossible to be like a normal.

His curiosity to know by asking questions help him to be more productive. This helps to avoid time wastage by not asking and ignoring one’s intuitions. He advises the young people to trust their guys in their professions, for it is essential in attaining success and developing leadership. See Related Link for more information.

He says the majority don’t agree with the fact that for one to achieve success in any profession, they must identify a human element. As an entrepreneur, he takes the business seriously and asks all leaders to do so and also to take oneself very seriously. The strategy that has helped him is communicating directly with customers to get direct feedback.

The challenge he faced was to choose a method between the one which was a norm and the one that was not a norm but was the right move. He encouraged readers to pursue the creation of an innovative biotech company. He has invested in education for others through donations. He uses the LinkedIn web as it allows him to streamline the content that he needs to view. He recommends the community to read ‘Outliers.’


More about Thiel on


Dr. Ira Kirschenbaum Is A Leading Orthopedic Surgeon In The United States

Orthopedic surgery is focused on treating and preventing various disorders that occur within the muscles, ligaments, bones, joints, and tendons throughout the human body. There are many MDs that are generalists and perform orthopedic surgery throughout the body, while others take a liking to specific areas of the body. Dr. Ira Kirschenbaum focuses on hip and knee orthopedic surgeries as well as joint reconstruction and joint replacement surgery.

Dr. Ira Kirschenbaum, MD, has a long list of accomplishments as an orthopedic surgeon, including his memberships to The American Board of Orthopedic Surgeons, The American Association of Hip and Knee Surgeons, and The American Academy of Orthopaedic Surgeons. At this point in his career, Dr. Ira Kirschenbaum has a major focus on his position as chairman at the BronxCare Health System. He has a distinguished role in leadership and focuses on maintaining the highest medical standards for himself and the many surgeons working throughout the BronxCare Health System.

Over the past 15 years, Dr. Ira Kirschenbaum has played the role of innovator in his field as a design expert with knowledge in information technology and engineering. This expertise helped Ira develop several different instruments that are now used in hip and knee replacement surgeries. He is also a member of the WebMD community, offering up his knowledge to help educate the general public and aspiring students of orthopedic surgery. Ira was the original founder of Medscape, and he directed the orthopedic website until it was eventually bought by WebMD and GQ.

Between acting as a chairman for the BronxCare Health System, consulting for the Stryker Corporation, acting as a managing partner for Sprocket Health, and working as a Chief Medical Officer at DTC Health, Dr. Ira Kirschenbaum has an extremely busy schedule. His plans for the future are heavily invested in technological developments for orthopedic surgery and to continue innovating the hip and knee replacement and restructuring processes.

Read through the article to see more about Dr Ira here

Carsten Thiel Joins EUSA Pharma In A Bid To Foster Its Growth And Expansion


The pharmaceutical industry is filled with very many people who have numerous certifications and are said to have attended the best schools in the world therefore it is a great milestone when someone is able to make it big in the industry. That is exactly what the Carsten Thiel, an alumnus of the University of Bristol has done.

Carsten Thiel started visualizing his rise to the top over 25 years ago. He then started laying the foundations of his career when he was in Malbrook, Germany, his native country, where he studied chemistry.

Mr. Thiel’s passion for pharmaceuticals prompted him to study even further. His burning desire to achieve more has truly yielded a lot of benefits as he is currently a holder of a PhD in Molecular Biology.

Carsten possesses impeccable skills, a rich education background and vast experience and for this reason very many companies want him on their team. This particular fight between giant pharmaceutical firms seems to have been won by EUSA Pharma, a biopharmaceutical company whose operations spans across the globe.

EUSA Pharma recently made several changes to their senior management team. The changes included the appointment of Carsten Thiel as the President of EUSA Pharma Europe and Darrel Cohen as the Head of Clinical Development.

Darrel Cohen, is a renowned oncologist with over 15 years of experience in the industry. Before joining EUSA Pharma, Darrel was the Vice President of Pfizer Global Oncology Organization. Mr. Cohen played an active role in the development of multiple oncology products like SUTENT while he was working at Pfizer. It is evident that he is very skilled in the field and is the right candidate to take up the position he has been appointed to.

He worked at Hoffman La Roche and Alexion Pharmaceuticals, two great firms in the pharmaceuticals industry, it is evident that Mr. Thiel will also bring something unique to EUSA Pharma.


Follow him on


Carsten Thiel And Pharmaceutical Proficiency


Carsten Thiel is the name of a well-known professional who has a lot of savvy that relates to biopharmaceutical and pharmaceutical matters. He’s a native of Berlin in Germany. Thiel is the kind of individual who likes to revel in the presences of his family members in the A.M. He makes a point to reach out to them while they’re eating breakfast in the quietest hours. He has a penchant for drinking coffee while eating.

Thiel was reared in a household that consisted of an abundance of doctors. That’s the reason that the medical realm has always been something that’s extremely familiar and close to him. He always believed that he’d emulate his parents’ vocational tracks. Thiel had a zeal for topics such as biology and science while he was a pupil. Thiel had a thirst for details that related to these subjects in any way.

This man believes that it’s critical for human beings to be in tune with intuition. Carsten Thiel thinks that people should strive to go with their instincts at all times. Thiel indicates that doing so can bring on kinds of rewards in the career sector.

Carsten Thiel is a big fan of the social media realm. That’s the reason that he employs the platform LinkedIn with significant frequency. LinkedIn is a beloved career networking site that’s been a major force on the Internet for quite a few years at this point.

He’s a part of the esteemed Board of Directors for a company that’s referred to simply as Karyopharm Therapeutics. There are various other individuals who serve on the board right next to Thiel. Some examples of these people are Director J. Scott Garland, Director Mikael Dolsten and, last but definitely not least, Chief Executive Officer and Director Michael G. Kauffman. These executives all work tirelessly. See This Article for more information.